Literature DB >> 2785474

Epidemiological study of asymptomatic inflammatory bowel disease: the identification of cases during a screening programme for colorectal cancer.

J F Mayberry1, K C Ballantyne, J D Hardcastle, C Mangham, G Pye.   

Abstract

An asymptomatic population of 37,000 people in the Nottingham area were offered faecal occult blood tests in a screening study for colorectal cancer. Seventeen thousand nine hundred and thirty people completed the tests and 481 individuals with positive tests underwent full investigation of the colon. Eight people with previously undiagnosed inflammatory bowel disease were identified. In five cases there was total ulcerative colitis; in one a proctitis and in two Crohn's disease. Two further patients with ulcerative colitis were identified; they had been lost to follow up for 25 and 45 years respectively. The combined prevalence of inflammatory bowel disease was 56/10(5) and it is likely that current studies of the epidemiology of these conditions may underestimate the true prevalence by between 27% and 38%.

Entities:  

Mesh:

Year:  1989        PMID: 2785474      PMCID: PMC1434023          DOI: 10.1136/gut.30.4.481

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  8 in total

1.  An epidemiological study of ulcerative colitis and regional enteritis in the Oxford area.

Authors:  J G Evans; E D Acheson
Journal:  Gut       Date:  1965-08       Impact factor: 23.059

Review 2.  Some aspects of the epidemiology of ulcerative colitis.

Authors:  J F Mayberry
Journal:  Gut       Date:  1985-09       Impact factor: 23.059

Review 3.  Epidemiological aspects of Crohn's disease: a review of the literature.

Authors:  J F Mayberry; J Rhodes
Journal:  Gut       Date:  1984-08       Impact factor: 23.059

4.  Accuracy of occult blood tests over a six-day period.

Authors:  P A Farrands; J D Hardcastle
Journal:  Clin Oncol       Date:  1983-09

5.  Familial prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease.

Authors:  J F Mayberry; J Rhodes; R G Newcombe
Journal:  Br Med J       Date:  1980-01-12

6.  The incidence and prevalence of inflammatory bowel disease in North Tees Health District.

Authors:  H B Devlin; D Datta; A W Dellipiani
Journal:  World J Surg       Date:  1980       Impact factor: 3.352

7.  Incidence of Crohn's disease in Cardiff between 1934-1977.

Authors:  J Mayberry; J Rhodes; L E Hughes
Journal:  Gut       Date:  1979-07       Impact factor: 23.059

8.  Incidence and prevalence of ulcerative colitis and Crohn's disease in the County of Copenhagen, 1962 to 1978.

Authors:  V Binder; H Both; P K Hansen; C Hendriksen; S Kreiner; K Torp-Pedersen
Journal:  Gastroenterology       Date:  1982-09       Impact factor: 22.682

  8 in total
  10 in total

1.  Incidence of ulcerative colitis in Cardiff over 20 years: 1968-87.

Authors:  E D Srivastava; J F Mayberry; T J Morris; P M Smith; G T Williams; G M Roberts; R G Newcombe; J Rhodes
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

2.  Epidemiological study of asymptomatic inflammatory bowel disease.

Authors:  F Namdaran
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

Review 3.  General surgery.

Authors:  I Taylor
Journal:  Postgrad Med J       Date:  1990-05       Impact factor: 2.401

4.  Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD).

Authors:  S Shivananda; J Lennard-Jones; R Logan; N Fear; A Price; L Carpenter; M van Blankenstein
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

5.  Role of upper gastrointestinal investigations in a screening study for colorectal neoplasia.

Authors:  W M Thomas; J D Hardcastle
Journal:  Gut       Date:  1990-11       Impact factor: 23.059

6.  Increasing rates and changing patterns of hospital admissions for patients with inflammatory bowel disease in Ireland: 1996-2001.

Authors:  C M Smyth; S Bacheer Picha; O Rathore; J Deasy; S E Patchett; F E Murray
Journal:  Ir J Med Sci       Date:  2005 Oct-Dec       Impact factor: 1.568

Review 7.  A Comprehensive Review of the Diagnosis and Pharmacological Management of Crohn's Disease in the Elderly Population.

Authors:  David Kim; Sasha Taleban
Journal:  Drugs Aging       Date:  2019-07       Impact factor: 3.923

8.  MicroRNA-139-5p regulates chronic inflammation by suppressing nuclear factor-κB activity to inhibit cell proliferation and invasion in colorectal cancer.

Authors:  Mingming Zhu; Wen Zhang; Jun Ma; Youguo Dai; Qi Zhang; Qin Liu; Burong Yang; Gang Li
Journal:  Exp Ther Med       Date:  2019-09-20       Impact factor: 2.447

Review 9.  Capturing the Biologic Onset of Inflammatory Bowel Diseases: Impact on Translational and Clinical Science.

Authors:  Dario Sorrentino; Vu Q Nguyen; Maithili V Chitnavis
Journal:  Cells       Date:  2019-06-06       Impact factor: 6.600

Review 10.  Diagnosis and natural history of preclinical and early inflammatory bowel disease.

Authors:  Iago Rodríguez-Lago; Yamile Zabana; Manuel Barreiro-de Acosta
Journal:  Ann Gastroenterol       Date:  2020-06-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.